Sponsor or institution
Clinical trials and research at AusperBio Therapeutics Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by AusperBio Therapeutics Inc. that are recruiting, at sites in 13 countries (most in Canada (1), France (1), Italy (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 13Countries
All recruiting trials (2)
-
AHB-137 for chronic hepatitis B in adults on nucleotide analogue therapy
AHB-137 is being tested to see if it is safe and effective for adults with chronic hepatitis B who are currently on nucleos(t)ide analogue therapy.
-
AHB-137 for HBeAg-negative chronic hepatitis B in the Asia–Pacific
This trial tests whether AHB-137 injections can improve outcomes for adults in the Asia–Pacific with HBeAg-negative chronic hepatitis B who are already on nucleos(t)ide therapy.
Quick answers
How many clinical trials run by AusperBio Therapeutics Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 13 countries. The most sites are in Canada (1 trial), France (1 trial), Italy (1 trial), Spain (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.